Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes.

MLA

Mobasheri, Ali, et al. “Molecular Taxonomy of Osteoarthritis for Patient Stratification, Disease Management and Drug Development: Biochemical Markers Associated with Emerging Clinical Phenotypes and Molecular Endotypes.” Current Opinion in Rheumatology, vol. 31, no. 1, Jan. 2019, pp. 80–89. EBSCOhost, https://doi.org/10.1097/BOR.0000000000000567.

APA

Mobasheri, A., van Spil, W. E., Budd, E., Uzieliene, I., Bernotiene, E., Bay-Jensen, A.-C., Larkin, J., Levesque, M. C., Gualillo, O., & Henrotin, Y. (2019). Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Current Opinion in Rheumatology, 31(1), 80–89. https://doi.org/10.1097/BOR.0000000000000567

Chicago

Mobasheri, Ali, Willem Evert van Spil, Emma Budd, Ilona Uzieliene, Eiva Bernotiene, Anne-Christine Bay-Jensen, Jonathan Larkin, Marc C Levesque, Oreste Gualillo, and Yves Henrotin. 2019. “Molecular Taxonomy of Osteoarthritis for Patient Stratification, Disease Management and Drug Development: Biochemical Markers Associated with Emerging Clinical Phenotypes and Molecular Endotypes.” Current Opinion in Rheumatology 31 (1): 80–89. doi:10.1097/BOR.0000000000000567.